IRIS
DE SANCTIS, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.058
EU - Europa 547
AS - Asia 126
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 5
SA - Sud America 5
Totale 2.821
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.020
FI - Finlandia 136
IE - Irlanda 112
IT - Italia 88
CN - Cina 66
NG - Nigeria 66
FR - Francia 51
DE - Germania 46
CA - Canada 38
TR - Turchia 31
SE - Svezia 29
NL - Olanda 25
GB - Regno Unito 22
BE - Belgio 14
IL - Israele 11
EU - Europa 10
IN - India 10
RU - Federazione Russa 6
AU - Australia 5
ES - Italia 4
IR - Iran 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
GR - Grecia 3
RO - Romania 3
BR - Brasile 2
MK - Macedonia 2
PL - Polonia 2
SI - Slovenia 2
AT - Austria 1
EE - Estonia 1
HK - Hong Kong 1
IQ - Iraq 1
SG - Singapore 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 2.821
Salva come PNG Salva come JPEG
Città #
Wilmington 467
Chandler 232
San Mateo 172
Ann Arbor 166
Helsinki 136
Dublin 112
Leawood 100
New York 87
Lawrence 85
Princeton 85
Boardman 70
Benin City 66
Shanghai 61
Fairfield 56
Ashburn 53
Paris 50
Woodbridge 44
Toronto 38
Kocaeli 31
Amsterdam 24
London 16
Brussels 14
Milan 12
Monmouth Junction 12
Phoenix 12
Los Angeles 8
Seattle 8
Norwalk 6
San Diego 6
Abbiategrasso 5
Pune 5
Bergamo 4
Ardabil 3
Buenos Aires 3
Chandigarh 3
Cisterna Di Latina 3
Falkenstein 3
Genova 3
Moscow 3
Redwood City 3
Sacramento 3
Arganda 2
Augusta 2
Austin 2
Beijing 2
Berlin 2
Bitola 2
Bradford 2
Clearwater 2
Des Moines 2
Henderson 2
Houston 2
Kemerovo 2
Las Vegas 2
Ljubljana 2
Melbourne 2
Redmond 2
Röllbach 2
São Paulo 2
A Coruña 1
Andover 1
Arlington 1
Athens 1
Basra 1
Bialystok 1
Buffalo 1
Champaign 1
Chicago 1
Collegeville 1
Frankfurt am Main 1
Groningen 1
Gunzenhausen 1
Hangzhou 1
Hillsboro 1
La Canada Flintridge 1
Mainz 1
Milwaukee 1
Pittsburgh 1
Pretoria 1
Raleigh 1
Saint Paul 1
Santa Clara 1
Sydney 1
Taipei 1
Tallinn 1
Tappahannock 1
Tel Aviv 1
Valladolid 1
Vancouver 1
Vienna 1
Washington 1
Zanjan 1
Totale 2.339
Salva come PNG Salva come JPEG
Nome #
Survival Outcome and Prognostic Factors After Pulmonary Metastasectomy in Sarcoma Patients A 18-Year Experience at a Single High-volume Referral Center 69
Biological characteristics and long-term outcomes in node-negative breast cancer 63
Response to Sunitinib in an Adult Patient With Rhabdoid Renal Cell Carcinoma 52
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 52
Colorectal cancer liver metastases treated with target therapies: monitoring response with constrat-enhanced ultrasonography (CE-US). 50
Atypical Lipomatous Tumors: Should They be Treated Like Other Sarcoma or Not? Surgical Consideration from a Bi-Institutional Experience 48
Carcinoma gastrico metastatico e Docetaxel, Cisplatino, Fluorouracile (DCF) settimanale: tolleranza e risposta 48
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 46
Early response evaluation of antiangiogenic therapy: use of contrast-enhanced ultrasonography (CE-US) in hepatocellular carcinoma 45
Zoledronic acid (ZA) and treatment of bone metastasis in patients with advanced lung cancer (NSCLC and SCLC). 44
Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC 43
Descripcion de un sistema de realidad virtual dirigido a la promocion de bienestar emocional en pazientes oncologicoa hospidalizados: ensayo fase II OncoHelp 42
Capecitabine in elderly patients with metastatic breast cancer 42
wALT trial (Phase I-II): weekly non-pegylated liposomal anthracycline and taxane combination in first line breast cancer chemotherapy 42
Prognostic factors and outcome of HER2+ breast cancer with CNS metastases 41
Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303 41
Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy 41
Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US). 41
First-line chemotherapy in over-70 patients with colon cancer. 41
WALT TRIAL (PHASE III): WEEKLY NON PEGYLATED LIPOSOMAL ANTHRACYCLINE AND TAXANE COMBINATION IN FIRSTLINE BREAST CANCER CHEMOTHERAPY 41
Unsupervised versus Supervised Identification of Prognostic Factors in Patients with Localized Retroperitoneal Sarcoma: A Data Clustering and Mahalanobis Distance Approach 40
HER2-positive breast cancer and CNS metastases: Prognostic factors and clinical outcome 40
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 40
Efficacy and tolerability of a single-day three drugs combination of aprepitant, palonosetron and dexamethasone in patients receiving moderately emetogenic chemotherapy 39
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 39
Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma 39
Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients 38
Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy? 38
Dietary chemoprevention of colorectal cancer 38
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab 38
Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study 37
A Study of Clinical Features and Risk Factors of Self-Referring Emergency Department Headache Patients: A Comparison with Headache Center Outpatients 36
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial 36
Never too old to fight breast cancer 35
Capecitabine in elderly breast cancer patients 35
Bevacizumab in combination with FOLFIRI as first-line treatment for metastatic colorectal cancer: outcomes from a single center experience 34
Efficacy of trabectedin in advanced soft tissue sarcoma: Beyond lipo- and leiomyosarcoma 34
Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: single center experience 33
TNBC universe: A monocentric retrospective analyses of TILs and AR as prognostic markers 32
Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity: a case report on the therapeutic regimen 32
A monocentric retrospective analysis of TILs and AR as hints for prognosis definition in TNBC 32
Trabectedin for the treatment of soft tissues sarcomas 31
Primary ovarian insufficiency associated with pazopanib therapy in a breast angiosarcoma patient A CARE-compliant case report 31
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 30
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group 30
Imatinib mesylate in desmoplastic small round cell tumors 29
Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors 29
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial 27
SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA 26
Palonosetron plus three-day aprepitant and dexamethasone schedule to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 26
Perfusion Computed Tomography as prognostic and predictive factor in patients with colorectal cancer liver metastases treated with bevacizumab 26
Palonosetron plus three-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 26
Role of Surgery in the Multimodal Treatment of Primary and Recurrent Leiomyosarcoma of the Inferior Vena Cava 26
Phase I, Pharmacokinetics (PK), Pharmacodynamic (PD) Study of Lapatinib (L) in Combination With Sorafenib (S) in Patients With Advanced Refractory Solid Tumours 26
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9) 26
SAFETY AND EFFICACY OF ORAL COMBINATION CHEMOTHERAPY IN METASTATIC BREAST CANCER: VINORELBINE AND CAPECITABINE 25
Imatinib mesylate in desmoplastic small round cell tumour 25
PERFUSION COMPUTED TOMOGRAPHY AS PROGNOSTIC AND PREDICTIVE FACTOR IN PATIENTS WITH COLORECTAL CANCER LIVER METASTASES TREATED WITH BEVACIZUMAB 25
A pilot analysis of headache disorders in breast cancer patients 25
The role of docetaxel in the multimodal treatment of non-small cell lung cancer 24
Safety, tolerability and early response evaluation of sarafenib in hepatocellular carcinoma in erderly: use of contrast-enhanced ultrasonography (CE-US). 24
Oral vinorelbine in elderly or unfit patients with metastatic NSCLC 23
Phase II study: Docetaxel-cisplatin and pro drug tegafur (TPF) as neoadjuvant treatment in advanced patients with head and neck cancer (HNC): Results and correlation between tandem magnesium/creatinine and toxicity 23
Juxtaglomerular cell tumor: Multicentric synchronous disease associated with paraneoplastic syndrome 23
Treatment of malignant pleural mesothelioma: current status and future directions 23
Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practice 23
Safety, Tollerability and Early Response Evaluation of Sorafenib In Hepatocellular Carcinoma In Elderly: Use of Contrast-enhanced Ultrasonography (ce-us) 22
Neutrophil to Lymphocyte Ratio (NLR) as predictive factor in patients with metastatic soft tissue sarcoma (STS) treated with trabectedin (T). 22
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds 21
Trabectedin for the treatment of soft tissue sarcoma 21
Safety and efficacy of oral combination of vinorelbine and capecitabine in metastatic breast cancer 21
Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer 21
The therapeutic potential of duloxetine in prostate cancer-related fatigue 20
Primary breast leiomyosarcoma and synchronous homolateral lung cancer: a case report 20
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 20
Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial 20
Never too old to fight breast cancer: A case report 20
Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: A phase I-II study from the Italian Sarcoma Group 20
Temporal–occipital glioblastoma presenting with Alice in Wonderland Syndrome in a patient with a long-time history of migraine without aura 20
Superiority of CHOI vs RECIST criteria in evaluating outcome of advanced soft tissue sarcoma (STS) patients treated with sorafenib 19
Sporadic desmoid tumors of the abdominal wall: the results of surgery 19
A systematic review of systematic reviews and pooled meta-analysis on pharmacological interventions to improve cancer-related fatigue 19
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 17
Real-life data on the cardiac toxicity of adjuvant fixed-dose subcutaneous trastuzumab in HER2-positive breast cancer 16
Defining T cell dysfunctionality in breast cancer by single cell analysis: Implications for immunotherapy 16
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: when, why and what? 16
Volumetric-modulated-arc-therapy versus 3D-conformal-radiotherapy for sarcoma of extremities 15
A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors 13
Re: Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients: Sympathetic nervous system activity on breast cancer: the story of migraine 13
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets 12
Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer 12
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy 12
Clinical Review on the Management of Breast Cancer Visceral Crisis 11
[The clinical significance of lymph node micrometastases and of concept of sentinel lymph node] 11
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 11
The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question 10
Opportunities and Challenges of Synthetic Data Generation in Oncology 10
[Integrated treatment of breast cancer: review of our experience] 9
Profiling the Spectrum of Headache Disorders on 440 Breast Cancer Patients: Highlights on Clinical and Pathological Mechanisms 8
Nomograms predicting local and distant recurrence and disease-specific mortality for R0/R1 soft tissue sarcomas of the extremities 8
Totale 2.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.560
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 0 0 0 0 0 0 0 0 0 0 0 58
2020/2021973 5 2 7 2 8 287 158 50 245 108 4 97
2021/2022445 32 2 15 79 14 7 12 64 44 77 89 10
2022/2023898 182 19 114 58 79 46 4 72 137 97 78 12
2023/2024568 54 63 164 34 30 110 52 32 8 21 0 0
Totale 2.942